“EVALUATION OF ANTIDIABETIC ACTIVITY OF HELICTERES

Angiotensin II type I receptor blockers, act competitively antagonise angiotensin II receptor type1 (AT1) receptor, reducing the end organ responses to angiotensin II. Administration of this results in a decrease in total peripheral resistance (afterload) and cardiac venous return (preload) All of the physiological effects of angiotensin II ... ................
................